MT
Margoob Tyagi
About Margoob Tyagi
Data last updated:
Margoob Tyagi is a Director at Domek Pharmaceutical Private Limited (since 2026), Additional Director at Domek International Builders Private Limited (since 2024) and Director at Agms Developers Private Limited (since 2016). The companies operate in Water Treatment and Software.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 18 Jul 2026 | 2026 | Active | ||
| Additional Director | 05 Jun 2024 | 2024 | Active | ||
| Director | 27 May 2016 | 2016 | Active |
Board colleagues of Margoob Tyagi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Rihan Tyagi | 10591775 | Domek Pharmaceutical Private Limited , Domek International Builders Private Limited | Director |
| Sadia Tyagi | 10656604 | Domek International Builders Private Limited | Additional Director |
| Gulista Tyagi | 07472318 | Agms Developers Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Margoob Tyagi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Margoob Tyagi
Margoob Tyagi currently holds 3 directorships: Domek Pharmaceutical Private Limited (Director, since 18 Jul 2026); Domek International Builders Private Limited (Additional Director, since 05 Jun 2024); Agms Developers Private Limited (Director, since 27 May 2016).
Margoob Tyagi was first appointed on 27 May 2016 as Director at Agms Developers Private Limited. The most recent appointment on record is 18 Jul 2026 at Domek Pharmaceutical Private Limited.
The current boards of Margoob Tyagi's companies include Rihan Tyagi (Domek Pharmaceutical Private Limited), Sadia Tyagi (Domek International Builders Private Limited), Gulista Tyagi (Agms Developers Private Limited).